Evidence map›Paper›PMID 40512553›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2026

Ultra-Processed Foods and Food Additives in CKD: Unveiling Hidden Risks and Advocating Smarter Food Choices.

Carla Maria Avesani, Valeria Cecchini, Alice Sabatino, Bengt Lindholm, Peter Stenvinkel, Daniela Canella, Kelly Picard

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carla Maria AvesaniDivision of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-4458-8358
Valeria CecchiniDivision of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0004-8330-5375
Alice SabatinoDivision of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2098-7597
Bengt LindholmDivision of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4269-4293
Peter StenvinkelDivision of Renal Medicine, Baxter Novum Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-8785-4820
Daniela CanellaDepartment of Applied Nutrition, Nutrition Institute, Rio de Janeiro State University, Rio de Janeiro, Brazil.ORCID 0000-0001-9672-4983
Kelly PicardBritish Columbia Renal Agency, Island Health Authority, Victoria, British Columbia, Canada.ORCID 0000-0002-6614-2672

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The term ultra-processed food (UPF) was developed almost two decades ago to define foods which have undergone sophisticated industrial processing. Many of these foods contain added sugars, unhealthy fats, salt, and food additives designed to enhance palatability, extend shelf life, and drive high sales. Owing to these convenient characteristics, the sales and consumption of UPF have consistently increased, with the tendency to replace minimally processed foods in the diet. This shift has led to a decrease in dietary quality and to an increase in the consumption of sugars, unhealthy fats, salt, and food additives, the latter raising concerns about potential toxicity. Therefore, UPF consumption has been associated with increased risk of developing noncommunicable diseases, including CKD, and may have an effect on kidney health in each CKD stage. Primary caregivers should be aware that UPF increases the risk of developing CKD. Providers of secondary and tertiary care should note that UPF contributes to the development of metabolic derangements such as metabolic acidosis, hyperkalemia, hyperphosphatemia, dyslipidemia, and dysbiosis. This review provides a summary of the main adverse effects of UPFs on general health as well as on kidney health. In addition, it gives practical guidance on how to define and assess UPF intake in research and clinical settings, with proposed strategies on how to address UPF consumption in individuals with CKD stages 3-5, aiming at reducing UPF consumption and increasing intake of minimally processed healthier food.

Indexed as

Fast FoodsFood AdditivesRenal Insufficiency, ChronicFood HandlingFood, ProcessedHumansRisk FactorsFood AdditivesCKDnutrition

Identifiers

PMID40512553
PMCPMC12889972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.